MedPath
TGA Approval

FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen (313902)

313902

FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen

AstraZeneca Pty Ltd

December 10, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/929079369fcc3b4558bf39651d423171.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1bbed5eacc90d80da154b15032d5c1e3.pdf

Active Ingredients

benralizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen (313902) - TGA 批准文号 | MedPath